XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019 54,290,383      
Beginning balance at Dec. 31, 2019 $ 210,033      
Redeemable Convertible Preferred Stock        
Issuance of redeemable convertible preferred stock, net of issuance (in shares) 17,935,533      
Issuance of redeemable convertible preferred stock, net of issuance costs $ 227,940      
Cumulative dividends and adjustments to redeemable convertible preferred stock $ 5,290      
Ending balance (in shares) at Dec. 31, 2020 72,225,916      
Ending balance at Dec. 31, 2020 $ 443,263      
Beginning balance (in shares) at Dec. 31, 2019   4,537,955    
Beginning balance at Dec. 31, 2019 (195,390) $ 5 $ 335 $ (195,730)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 1,954   1,954  
Preferred Series E Tranche Liability (892)   (892)  
Exercised stock options (in shares)   1,706,780    
Exercised stock options 1,986 $ 2 1,984  
Cumulative dividends and adjustments to redeemable convertible preferred stock (5,290)   (3,381) (1,909)
Repurchase of common stock in tender offer (in shares)   (1,099,373)    
Repurchase of common stock in tender offer (11,329) $ (2)   (11,327)
Repurchase of common stock (in shares)   (235,833)    
Repurchase of common stock (3,207)     (3,207)
Net loss (51,355)     (51,355)
Ending balance (in shares) at Dec. 31, 2020   4,909,529    
Ending balance at Dec. 31, 2020 (263,523) $ 5   (263,528)
Redeemable Convertible Preferred Stock        
Cumulative dividends and adjustments to redeemable convertible preferred stock 277      
Payment of Series B Dividend upon initial public offering $ (4,969)      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (72,225,916)      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ (438,571)      
Ending balance (in shares) at Dec. 31, 2021 0      
Ending balance at Dec. 31, 2021 $ 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation $ 14,535   14,535  
Exercised stock options (in shares) 5,801,124 5,801,124    
Exercised stock options $ 9,112 $ 6 9,106  
Issuance of common stock upon restricted stock unit vesting (in shares)   3,368    
Common stock issued under Employee Stock Purchase Plan (ESPP) (in shares)   122,314    
Common stock issued under Employee Stock Purchase Plan (ESPP) 3,005   3,005  
Exercised warrants (in shares)   211,323    
Exercised warrants 645   645  
Cumulative dividends and adjustments to redeemable convertible preferred stock (277)   (277)  
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other offering costs (in shares)   6,900,000    
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other offerings costs 192,810 $ 7 192,803  
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)   72,225,916    
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 438,570 $ 72 438,498  
Conversion of redeemable convertible preferred stock warrants to common stock warrants upon initial public offering 5,727   5,727  
Cost in connection with initial public offering (5,674)   (5,674)  
Repurchase of common stock (in shares)   (218,917)    
Repurchase of common stock (3,497)   6 (3,503)
Net loss (46,822)     (46,822)
Ending balance (in shares) at Dec. 31, 2021   89,954,657    
Ending balance at Dec. 31, 2021 $ 344,611 $ 90 658,374 (313,853)
Ending balance (in shares) at Dec. 31, 2022 0      
Ending balance at Dec. 31, 2022 $ 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation $ 45,395   45,395  
Exercised stock options (in shares) 1,135,346 1,135,346    
Exercised stock options $ 2,399 $ 1 2,398  
Issuance of common stock upon restricted stock unit vesting (in shares)   698,841    
Issuance of common stock upon restricted stock unit vesting   $ 1 (1)  
Common stock issued under Employee Stock Purchase Plan (ESPP) (in shares) 323,905 323,905    
Common stock issued under Employee Stock Purchase Plan (ESPP) $ 2,906   2,906  
Payments for taxes related to net settlement of equity awards (2,665)   (2,665)  
Net loss (58,600)     (58,600)
Ending balance (in shares) at Dec. 31, 2022   92,112,749    
Ending balance at Dec. 31, 2022 $ 334,046 $ 92 $ 706,407 $ (372,453)